Fenton Dennis M
SEC-identified person · CIK 1184627 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| First Tracks Biotherapeutics, Inc. TRAX | Director | filed 2026 - 2026 |
| Anaptysbio, INC ANAB | Director | filed 2018 - 2026 |
| Portola Pharmaceuticals INC PTLA | Director | filed 2015 - 2020 |
| Sienna Biopharmaceuticals, Inc. SNNA | Director | filed 2017 - 2019 |
| Pfenex Inc. PFNX | Director | filed 2015 - 2017 |
| Xenoport INC XNPT | Director | filed 2009 - 2016 |
| Kythera Biopharmaceuticals INC KYTH | Director | filed 2012 - 2015 |
| Hospira INC HSP | Director | filed 2012 - 2015 |
| Dendreon Corp DNDNQ | Director | filed 2011 - 2014 |
| Genzyme Corp u4yfvwk$ | Director | filed 2010 - 2011 |
| Amgen INC AMGN | Executive V.P., Operations | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.